ALB and COVID-19: The rate of normalization of LFTs at 6 months was much higher than in our cohort, which could be explained by the younger median age (45 years) and lower proportion of severe COVID‐19 (20%) in addition to overreporting of patients with abnormal LFTs due to the inclusion of albumin as one of the parameters.